New York Methodist — Brooklyn, New York

New York Methodist is a clinical research site located in Brooklyn, New York, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Methodist has participated in 1 clinical trials.

Therapeutic areas: Kidney Failure, Acute.

Sponsors: Abbott RDx Cardiometabolic.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Methodist?

New York Methodist has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Methodist conducted?

New York Methodist has 1 clinical trials on record. Their work covers Kidney Failure, Acute.

Is New York Methodist accredited by Crixeo Health?

New York Methodist has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Methodist?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.